Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan.

Sakurai A, Ogawa T, Matsumoto J, Kihira T, Fukushima S, Miyata I, Shimizu H, Itamura S, Ouchi K, Hamada A, Tani K, Okabe N, Yamaguchi T.

Vaccine. 2019 Sep 7. pii: S0264-410X(19)31095-3. doi: 10.1016/j.vaccine.2019.08.031. [Epub ahead of print]

2.

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.

Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators.

N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14.

PMID:
30763142
3.

Dietary patterns and prostate cancer risk in Japanese: the Japan Public Health Center-based Prospective Study (JPHC Study).

Shin S, Saito E, Sawada N, Ishihara J, Takachi R, Nanri A, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S; JPHC Study Group.

Cancer Causes Control. 2018 Jun;29(6):589-600. doi: 10.1007/s10552-018-1030-3. Epub 2018 Apr 18.

PMID:
29671180
4.

Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack.

Yoshida Y, Wang H, Hiwasa T, Machida T, Kobayashi E, Mine S, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Takizawa H, Kashiwado K, Kamitsukasa I, Shin H, Wada T, Aotsuka A, Nishi E, Ohno M, Takemoto M, Yokote K, Takahashi S, Matsushima J, Zhang XM, Takiguchi M, Iwadate Y.

Oncotarget. 2017 Dec 24;9(10):8836-8848. doi: 10.18632/oncotarget.23653. eCollection 2018 Feb 6.

5.

Correction to: Effects of periodontal treatment on carotid intima-media thickness in patients with lifestyle-related diseases: Japanese prospective multicentre observational study.

Kudo C, Shin WS, Sasaki N, Harai K, Kato K, Seino H, Goke E, Fujino T, Kuribayashi N, Pearce YO, Taira M, Matsushima R, Minabe M, Takashiba S; Periodontitis and Atherosclerosis Project-Tokyo and Chiba Consortiums.

Odontology. 2018 Jul;106(3):349. doi: 10.1007/s10266-018-0346-5.

PMID:
29464471
6.

Increased diversity with reduced "diversity evenness" of tumor infiltrating T-cells for the successful cancer immunotherapy.

Hosoi A, Takeda K, Nagaoka K, Iino T, Matsushita H, Ueha S, Aoki S, Matsushima K, Kubo M, Morikawa T, Kitaura K, Suzuki R, Kakimi K.

Sci Rep. 2018 Jan 18;8(1):1058. doi: 10.1038/s41598-018-19548-y.

7.

Effects of periodontal treatment on carotid intima-media thickness in patients with lifestyle-related diseases: Japanese prospective multicentre observational study.

Kudo C, Shin WS, Sasaki N, Harai K, Kato K, Seino H, Goke E, Fujino T, Kuribayashi N, Pearce YO, Taira M, Matsushima R, Minabe M, Takashiba S; Periodontitis and Atherosclerosis Project-Tokyo and Chiba Consortiums.

Odontology. 2018 Jul;106(3):316-327. doi: 10.1007/s10266-017-0331-4. Epub 2018 Jan 12. Erratum in: Odontology. 2018 Feb 20;:.

PMID:
29330707
8.

Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.

Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA, Saito K, Servais L, Tizzano E, Topaloglu H, Tulinius M, Montes J, Glanzman AM, Bishop K, Zhong ZJ, Gheuens S, Bennett CF, Schneider E, Farwell W, De Vivo DC; ENDEAR Study Group.

N Engl J Med. 2017 Nov 2;377(18):1723-1732. doi: 10.1056/NEJMoa1702752.

9.

Dietary patterns and colorectal cancer risk in middle-aged adults: A large population-based prospective cohort study.

Shin S, Saito E, Sawada N, Ishihara J, Takachi R, Nanri A, Shimazu T, Yamaji T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S; JPHC Study Group.

Clin Nutr. 2018 Jun;37(3):1019-1026. doi: 10.1016/j.clnu.2017.04.015. Epub 2017 May 5.

PMID:
28526274
10.

Functional dissection of the N-terminal sequence of Clostridium sp. G0005 glucoamylase: identification of components critical for folding the catalytic domain and for constructing the active site structure.

Sakaguchi M, Matsushima Y, Nagamine Y, Matsuhashi T, Honda S, Okuda S, Ohno M, Sugahara Y, Shin Y, Oyama F, Kawakita M.

Appl Microbiol Biotechnol. 2017 Mar;101(6):2415-2425. doi: 10.1007/s00253-016-8024-4. Epub 2016 Dec 9.

PMID:
27942757
11.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group.

Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1.

12.

Platelet Aggregation Inhibitory Effects and Pharmacokinetics of Prasugrel Used in Combination With Aspirin in Healthy Japanese Subjects.

Umemura K, Ikeda Y, Matsushima N, Kondo K.

Clin Pharmacol Drug Dev. 2017 Jul;6(4):398-407. doi: 10.1002/cpdd.308. Epub 2016 Oct 26.

13.

Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events COPE Trial Group.

Hypertens Res. 2016 Jan;39(1):46-53. doi: 10.1038/hr.2015.104. Epub 2015 Oct 22.

14.

Analysis of the relationship between periodontal disease and atherosclerosis within a local clinical system: a cross-sectional observational pilot study.

Kudo C, Shin WS, Minabe M, Harai K, Kato K, Seino H, Goke E, Sasaki N, Fujino T, Kuribayashi N, Pearce YO, Taira M, Maeda H, Takashiba S; Periodontitis and Atherosclerosis Project-Tokyo and Chiba Consortiums.

Odontology. 2015 Sep;103(3):314-21. doi: 10.1007/s10266-014-0172-3. Epub 2014 Aug 14.

PMID:
25119713
15.

Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial.

Rakugi H, Ogihara T, Umemoto S, Matsuzaki M, Matsuoka H, Shimada K, Higaki J, Ito S, Kamiya A, Suzuki H, Ohashi Y, Shimamoto K, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.

Hypertens Res. 2013 Nov;36(11):947-58. doi: 10.1038/hr.2013.63. Epub 2013 Jul 18.

PMID:
23864054
16.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
17.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

18.

Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial.

Matsuzaki M, Ogihara T, Umemoto S, Rakugi H, Matsuoka H, Shimada K, Abe K, Suzuki N, Eto T, Higaki J, Ito S, Kamiya A, Kikuchi K, Suzuki H, Tei C, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial Group.

J Hypertens. 2011 Aug;29(8):1649-59. doi: 10.1097/HJH.0b013e328348345d.

PMID:
21610513
19.

Variety of laminin expressions in murine neoplastic cell-lines - neuroblastoma na cells produce only laminin-b2 chain.

Narumi K, Satoh K, Isemura M, Sakai T, Abe T, Shindo S, Kikuchi T, Matsushima K, Motomiya M, Nukiwa T.

Int J Oncol. 1994 Jan;4(1):133-6.

PMID:
21566902
20.

[Intraenamel microfibril. 2].

Imanishi I, Kariyama M, Hosoi M, Matsushima R, Shin M.

Hiroshima Daigaku Shigaku Zasshi. 1971;3(2):138-42. Japanese. No abstract available.

PMID:
5290265

Supplemental Content

Loading ...
Support Center